Philipp Zanger

2.4k total citations
56 papers, 1.4k citations indexed

About

Philipp Zanger is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Philipp Zanger has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in Philipp Zanger's work include Antimicrobial Resistance in Staphylococcus (21 papers), Streptococcal Infections and Treatments (8 papers) and Bacterial biofilms and quorum sensing (8 papers). Philipp Zanger is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (21 papers), Streptococcal Infections and Treatments (8 papers) and Bacterial biofilms and quorum sensing (8 papers). Philipp Zanger collaborates with scholars based in Germany, Sweden and Netherlands. Philipp Zanger's co-authors include Dennis Nurjadi, Sabine Gabrysch, Peter G. Kremsner, Regina Schleucher, Klaus Heeg, Frank P. Mockenhaupt, Sabrina Klein, Birgit Schittek, Ina Kötter and Juliane Schwille‐Kiuntke and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Philipp Zanger

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Zanger Germany 24 668 466 307 199 189 56 1.4k
Clare Ling United Kingdom 19 268 0.4× 413 0.9× 208 0.7× 334 1.7× 124 0.7× 53 1.2k
Cédric P. Yansouni Canada 20 785 1.2× 234 0.5× 138 0.4× 434 2.2× 148 0.8× 73 1.7k
Tamrat Abebe Ethiopia 26 504 0.8× 457 1.0× 232 0.8× 871 4.4× 129 0.7× 122 1.9k
Kamal Hamed United States 29 816 1.2× 562 1.2× 155 0.5× 978 4.9× 179 0.9× 117 2.2k
Shima Mahmoudi Iran 24 990 1.5× 237 0.5× 246 0.8× 627 3.2× 159 0.8× 163 2.0k
Μαρία Καντζάνου Greece 21 1.1k 1.6× 398 0.9× 669 2.2× 593 3.0× 235 1.2× 78 2.1k
Robert M. Rakita United States 25 833 1.2× 206 0.4× 236 0.8× 841 4.2× 186 1.0× 66 2.0k
Norbert Georg Schwarz Germany 24 542 0.8× 656 1.4× 116 0.4× 237 1.2× 94 0.5× 81 1.6k
Jonathan R. Hibbs United States 21 582 0.9× 308 0.7× 373 1.2× 824 4.1× 372 2.0× 34 2.9k
Sasheela Ponnampalavanar Malaysia 22 674 1.0× 427 0.9× 199 0.6× 348 1.7× 125 0.7× 97 1.5k

Countries citing papers authored by Philipp Zanger

Since Specialization
Citations

This map shows the geographic impact of Philipp Zanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Zanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Zanger more than expected).

Fields of papers citing papers by Philipp Zanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Zanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Zanger. The network helps show where Philipp Zanger may publish in the future.

Co-authorship network of co-authors of Philipp Zanger

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Zanger. A scholar is included among the top collaborators of Philipp Zanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Zanger. Philipp Zanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schoeps, Anja, Dietmar Hoffmann, Tina Kaffenberger, et al.. (2021). Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany. Epidemiology and Infection. 149. e213–e213. 18 indexed citations
3.
4.
Nurjadi, Dennis, Klaus Heeg, Alexander N.R. Weber, & Philipp Zanger. (2018). Toll-like receptor 9 (TLR-9) promotor polymorphisms and gene expression are associated with persistent Staphylococcus aureus nasal carriage. Clinical Microbiology and Infection. 24(11). 1210.e7–1210.e12. 16 indexed citations
5.
6.
Nurjadi, Dennis, Jacob Schäfer, B. Friedrich-Jänicke, et al.. (2015). Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus. Clinical Microbiology and Infection. 21(12). 1095.e5–1095.e9. 31 indexed citations
7.
Nurjadi, Dennis, B. Friedrich-Jänicke, Jacob Schäfer, et al.. (2015). Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe. Clinical Microbiology and Infection. 21(6). 567.e1–567.e10. 66 indexed citations
8.
Zanger, Philipp, et al.. (2012). Hormonal Contraceptive Use and Persistent Staphylococcus aureus Nasal Carriage. Clinical Infectious Diseases. 55(12). 1625–1632. 30 indexed citations
9.
Nurjadi, Dennis, Jacques LePendu, Peter G. Kremsner, & Philipp Zanger. (2012). Staphylococcus aureus throat carriage is associated with ABO-/secretor status. Journal of Infection. 65(4). 310–317. 28 indexed citations
10.
Olalekan, Adesola, Frieder Schaumburg, Dennis Nurjadi, et al.. (2012). Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIV-positive individuals in Lagos, Nigeria. International Journal of Antimicrobial Agents. 40(3). 268–272. 32 indexed citations
11.
Nurjadi, Dennis, et al.. (2012). Impaired β-Defensin Expression in Human Skin Links DEFB1 Promoter Polymorphisms With Persistent Staphylococcus aureus Nasal Carriage. The Journal of Infectious Diseases. 207(4). 666–674. 54 indexed citations
12.
Zanger, Philipp, et al.. (2011). Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe. Clinical Microbiology and Infection. 18(7). 670–676. 46 indexed citations
13.
14.
Zanger, Philipp, et al.. (2011). Successful Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica with Liposomal Amphothericin B in an Immunocompromised Traveler Returning from Eritrea. American Journal of Tropical Medicine and Hygiene. 84(5). 692–694. 26 indexed citations
15.
Zanger, Philipp. (2010). Staphylococcus aureus positive skin infections and international travel. Wiener klinische Wochenschrift. 122(S1). 31–33. 12 indexed citations
16.
Buchholz, Ulrike, Robin Kobbe, Ina Danquah, et al.. (2010). Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants. Malaria Journal. 9(1). 244–244. 10 indexed citations
17.
Held, Jana, Philipp Zanger, Saadou Issifou, Peter G. Kremsner, & Benjamin Mordmüller. (2010). In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon. International Journal of Antimicrobial Agents. 35(6). 587–589. 13 indexed citations
18.
Schleucher, Regina, et al.. (2008). Successful Diagnosis and Treatment 50 Years After Exposure: Is Mucocutaneous Leishmaniasis Still a Neglected Differential Diagnosis?. Journal of Travel Medicine. 15(6). 466–467. 6 indexed citations
19.
Cramer, Jakob P., Andreas K. Nüssler, Stephan Ehrhardt, et al.. (2005). Age‐dependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria. Tropical Medicine & International Health. 10(7). 672–680. 23 indexed citations
20.
Zanger, Philipp, et al.. (2002). Inflammatorischer, myofibroblastischer Tumor des Pankreas mit Beteiligung regionärer Lymphknoten. Der Pathologe. 23(2). 161–166. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare Ling Breakdown of academic impact, for papers by Cédric P. Yansouni Breakdown of academic impact, for papers by Tamrat Abebe Breakdown of academic impact, for papers by Kamal Hamed Breakdown of academic impact, for papers by Shima Mahmoudi Breakdown of academic impact, for papers by Μαρία Καντζάνου Breakdown of academic impact, for papers by Robert M. Rakita Breakdown of academic impact, for papers by Norbert Georg Schwarz Breakdown of academic impact, for papers by Jonathan R. Hibbs Breakdown of academic impact, for papers by Sasheela Ponnampalavanar
Rankless by CCL
2026